• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 后冠状病毒病在实体器官移植受者中的流行情况:国家 COVID 队列协作中的风险评估。

The prevalence of postacute sequelae of coronavirus disease 2019 in solid organ transplant recipients: Evaluation of risk in the National COVID Cohort Collaborative.

机构信息

Division of Nephrology, Department of Medicine, Victoria General Hospital, Dalhousie University, Halifax, Nova Scotia, Canada.

Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, USA.

出版信息

Am J Transplant. 2024 Sep;24(9):1675-1689. doi: 10.1016/j.ajt.2024.06.001. Epub 2024 Jun 8.

DOI:10.1016/j.ajt.2024.06.001
PMID:38857785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11390303/
Abstract

Postacute sequelae after the coronavirus disease (COVID) of 2019 (PASC) is increasingly recognized, although data on solid organ transplant (SOT) recipients (SOTRs) are limited. Using the National COVID Cohort Collaborative, we performed 1:1 propensity score matching (PSM) of all adult SOTR and nonimmunosuppressed/immunocompromised (ISC) patients with acute COVID infection (August 1, 2021 to January 13, 2023) for a subsequent PASC diagnosis using International Classification of Diseases, 10th Revision, Clinical Modification codes. Multivariable logistic regression was used to examine not only the association of SOT status with PASC, but also other patient factors after stratifying by SOT status. Prior to PSM, there were 8769 SOT and 1 576 769 non-ISC patients with acute COVID infection. After PSM, 8756 SOTR and 8756 non-ISC patients were included; 2.2% of SOTR (n = 192) and 1.4% (n = 122) of non-ISC patients developed PASC (P value < .001). In the overall matched cohort, SOT was independently associated with PASC (adjusted odds ratio [aOR], 1.48; 95% confidence interval [CI], 1.09-2.01). Among SOTR, COVID infection severity (aOR, 11.6; 95% CI, 3.93-30.0 for severe vs mild disease), older age (aOR, 1.02; 95% CI, 1.01-1.03 per year), and mycophenolate mofetil use (aOR, 2.04; 95% CI, 1.38-3.05) were each independently associated with PASC. In non-ISC patients, only depression (aOR, 1.96; 95% CI, 1.24-3.07) and COVID infection severity were. In conclusion, PASC occurs more commonly in SOTR than in non-ISC patients, with differences in risk profiles based on SOT status.

摘要

2019 年冠状病毒病(COVID)的急性后遗症(PASC)日益受到关注,尽管有关实体器官移植(SOT)受者(SOTR)的数据有限。利用国家 COVID 队列协作研究,我们对所有成年 SOTR 和无免疫抑制/免疫功能低下(ISC)的急性 COVID 感染患者(2021 年 8 月 1 日至 2023 年 1 月 13 日)进行了 1:1 倾向评分匹配(PSM),以使用国际疾病分类,第十版,临床修正版代码诊断随后的 PASC。多变量逻辑回归不仅用于检查 SOT 状态与 PASC 的关联,还用于在按 SOT 状态分层后检查其他患者因素。在 PSM 之前,有 8769 名 SOT 和 1576769 名非 ISC 急性 COVID 感染患者。PSM 后,纳入 8756 名 SOTR 和 8756 名非 ISC 患者;SOTR 中有 2.2%(n=192)和非 ISC 患者中有 1.4%(n=122)发生 PASC(P 值<0.001)。在整个匹配队列中,SOT 与 PASC 独立相关(调整优势比 [aOR],1.48;95%置信区间 [CI],1.09-2.01)。在 SOTR 中,COVID 感染严重程度(aOR,11.6;95%CI,3.93-30.0 用于严重疾病与轻度疾病)、年龄较大(aOR,1.02;95%CI,每年 1.01-1.03)和吗替麦考酚酯使用(aOR,2.04;95%CI,1.38-3.05)均与 PASC 独立相关。在非 ISC 患者中,只有抑郁(aOR,1.96;95%CI,1.24-3.07)和 COVID 感染严重程度是相关的。总之,PASC 在 SOTR 中比在非 ISC 患者中更常见,基于 SOT 状态的风险特征存在差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a416/11390303/8d54d4d801c1/nihms-2013874-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a416/11390303/8d54d4d801c1/nihms-2013874-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a416/11390303/8d54d4d801c1/nihms-2013874-f0001.jpg

相似文献

1
The prevalence of postacute sequelae of coronavirus disease 2019 in solid organ transplant recipients: Evaluation of risk in the National COVID Cohort Collaborative.COVID-19 后冠状病毒病在实体器官移植受者中的流行情况:国家 COVID 队列协作中的风险评估。
Am J Transplant. 2024 Sep;24(9):1675-1689. doi: 10.1016/j.ajt.2024.06.001. Epub 2024 Jun 8.
2
Outcomes of COVID-19 in Solid Organ Transplant Recipients: A Propensity-matched Analysis of a Large Research Network.实体器官移植受者 COVID-19 结局:大型研究网络的倾向匹配分析。
Transplantation. 2021 Jun 1;105(6):1365-1371. doi: 10.1097/TP.0000000000003670.
3
The Relative Risk of COVID-19 in Solid Organ Transplant Recipients Over Waves of the Pandemic.实体器官移植受者在各波大流行中 COVID-19 的相对风险。
Transpl Int. 2024 Sep 6;37:13351. doi: 10.3389/ti.2024.13351. eCollection 2024.
4
Post-acute sequelae of COVID-19 in solid organ transplant recipients.COVID-19 后在实体器官移植受者中的后遗症。
Transpl Infect Dis. 2023 Dec;25(6):e14167. doi: 10.1111/tid.14167. Epub 2023 Nov 3.
5
Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) After Infection During Pregnancy.感染 SARS-CoV-2 后孕妇的严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)的急性后期后遗症。
Obstet Gynecol. 2024 Sep 1;144(3):411-420. doi: 10.1097/AOG.0000000000005670. Epub 2024 Jul 11.
6
The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls.实体器官移植受者相对于非免疫抑制对照者突破性 SARS-CoV-2 感染的风险和后果。
Am J Transplant. 2022 Oct;22(10):2418-2432. doi: 10.1111/ajt.17117. Epub 2022 Jun 20.
7
Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population.激素替代疗法与实体器官移植受者 COVID-19 结局与普通人群的比较。
Am J Transplant. 2023 Jul;23(7):1035-1047. doi: 10.1016/j.ajt.2023.04.020. Epub 2023 Apr 26.
8
Severe coronavirus disease 2019 in pediatric solid organ transplant recipients: Big data convergence study in Korea (K-COV-N cohort).韩国(K-COV-N 队列)的大数据融合研究:儿科实体器官移植受者的严重 2019 年冠状病毒病
Int J Infect Dis. 2023 Sep;134:220-227. doi: 10.1016/j.ijid.2023.06.016. Epub 2023 Jun 21.
9
A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients.一项与非实体器官移植患者相比 COVID-19 实体器官移植患者死亡率的倾向评分匹配分析。
PLoS One. 2021 Mar 3;16(3):e0247251. doi: 10.1371/journal.pone.0247251. eCollection 2021.
10
COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study.COVID-19 住院肺和非肺实体器官移植受者:一项多中心研究的对比分析。
Am J Transplant. 2021 Aug;21(8):2774-2784. doi: 10.1111/ajt.16692. Epub 2021 Jul 24.

引用本文的文献

1
Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions.2019冠状病毒病(COVID-19)真实世界数据基础设施:用于研究COVID-19对免疫功能低下患者群体影响的大数据资源。
Open Forum Infect Dis. 2025 Jan 23;12(1):ofaf021. doi: 10.1093/ofid/ofaf021. eCollection 2025 Jan.
2
Reply: Response to Clinical Outcomes of Solid Organ Transplant Recipients Hospitalized with COVID-19: A Propensity Score-Matched Cohort Study.回复:对因 COVID-19 住院的实体器官移植受者的临床结局的回应:一项倾向评分匹配队列研究。
Infect Chemother. 2024 Sep;56(3):417-418. doi: 10.3947/ic.2024.0076.

本文引用的文献

1
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.开发 SARS-CoV-2 感染后后遗症的定义。
JAMA. 2023 Jun 13;329(22):1934-1946. doi: 10.1001/jama.2023.8823.
2
Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population.激素替代疗法与实体器官移植受者 COVID-19 结局与普通人群的比较。
Am J Transplant. 2023 Jul;23(7):1035-1047. doi: 10.1016/j.ajt.2023.04.020. Epub 2023 Apr 26.
3
Coding long COVID: characterizing a new disease through an ICD-10 lens.
长新冠编码:通过 ICD-10 视角描述一种新疾病。
BMC Med. 2023 Feb 16;21(1):58. doi: 10.1186/s12916-023-02737-6.
4
Long COVID: major findings, mechanisms and recommendations.长新冠:主要发现、机制和建议。
Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
5
High Prevalence of Long-COVID Among Kidney Transplant Recipients: A Longitudinal Cohort Study.肾移植受者中长新冠病毒的高患病率:一项纵向队列研究。
Transplantation. 2022 Dec 1;106(12):2408-2415. doi: 10.1097/TP.0000000000004359. Epub 2022 Oct 13.
6
PASC in Solid Organ Transplant Recipients With Self-reported SARS-CoV-2 Infection.有自我报告 SARS-CoV-2 感染的实体器官移植受者中的 PASC。
Transplantation. 2023 Jan 1;107(1):181-191. doi: 10.1097/TP.0000000000004340. Epub 2022 Sep 19.
7
Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review.2019冠状病毒病疫苗接种对发生长期新冠病毒病风险及现有长期新冠病毒病症状的影响:一项系统评价
EClinicalMedicine. 2022 Aug 27;53:101624. doi: 10.1016/j.eclinm.2022.101624. eCollection 2022 Nov.
8
Associations of health-related quality of life with depression and stigma in MERS-CoV survivors during the recovery period.恢复期中东呼吸综合征冠状病毒幸存者的健康相关生活质量与抑郁和污名之间的关联。
Medicine (Baltimore). 2022 Jun 24;101(25):e29440. doi: 10.1097/MD.0000000000029440.
9
Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2.与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的德尔塔变异株和奥密克戎变异株相关的长期新冠风险。
Lancet. 2022 Jun 18;399(10343):2263-2264. doi: 10.1016/S0140-6736(22)00941-2.
10
The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls.实体器官移植受者相对于非免疫抑制对照者突破性 SARS-CoV-2 感染的风险和后果。
Am J Transplant. 2022 Oct;22(10):2418-2432. doi: 10.1111/ajt.17117. Epub 2022 Jun 20.